News

EMA examines warnings of anaphylactic reactions to Rienso

EMA examines warnings of anaphylactic reactions to Rienso

09-05-2014

The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) started two…

Anaphylactic reactionsEuropeHealthLong-term kidney diseaseMedicinePharmaceuticalPharmacovigilance Risk Assessment CommitteeRegulationRienso

Back to top